Top Markets
#1 Helium Helium +108.34%
#2 MowCat MowCat +101.34%
#3 Seeker Seeker +77.99%
#4 AI XOVIA AI XOVIA +45.07%
#5 Pons Pons +39.63%
#6 UnifAI Network UnifAI Network +33.66%
#7 Bounce Bounce +32.28%
#8 Tensor Tensor +23.04%
#9 Zylo Ecosystem Zylo Ecosystem +21.68%
#10 pipedog pipedog +21.23%
Coin of the day
Helium Helium
Instellingen
Taal
DUTCH
Valuta
USD
Thema
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc.

BBOT
Rang in aandelen #11443
BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical... BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical firm dedicated to pioneering advanced small molecule treatments. These therapies are aimed at combating malignancies driven by RAS and PI3Kα, both frequently encountered oncogenes in human cancers. Initially established as an offshoot of BridgeBio Pharma, the company concentrates on precision oncology. Its developmental pipeline features several promising programs, including BBO-8520, BBO-10203, and BBO-11818, all specifically designed to modulate the KRAS and PI3K pathways. The company recently became publicly traded through a business combination with Helix Acquisition Corp. II. This strategic move successfully raised approximately $450 million, which will be utilized to further its clinical development initiatives. The leadership team comprises Dr. Eli Wallace as Chief Executive Officer and Dr. Pedro Beltran as Chief Scientific Officer.
Aandeelprijs
$8.74
Laatst gesynchroniseerd: 2026-08-28
Marktkapitalisatie
$699.74M
Verandering (1 dag)
-4.85%
Verandering (1 jaar)
-2.29%
Land
US
Handel BridgeBio Oncology Therapeutics Inc. (BBOT)

Categorie

Healthcare
EPS voor BridgeBio Oncology Therapeutics Inc. (BBOT)
EPS per 2026 TTM: 0
Volgens de laatste financiële rapporten en de aandelenkoers van BridgeBio Oncology Therapeutics Inc. is de huidige EPS van het bedrijf (TTM) 0. Eind 2026 had het bedrijf een EPS van 0, gelijk aan de EPS van 2026 die 0 bedroeg.
EPS-geschiedenis van BridgeBio Oncology Therapeutics Inc. van 2026 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH